These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2886883)

  • 1. EC array sensor concepts and data.
    Matson WR; Gamache PG; Beal MF; Bird ED
    Life Sci; 1987 Aug; 41(7):905-8. PubMed ID: 2886883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable o-phthalaldehyde-sulphite derivatives.
    Pearson SJ; Czudek C; Mercer K; Reynolds GP
    J Neural Transm Gen Sect; 1991; 86(2):151-7. PubMed ID: 1683240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic analysis of neurotransmitter amino acids in brain.
    Durkin TA; Anderson GM; Cohen DJ
    J Chromatogr; 1988 Jun; 428(1):9-15. PubMed ID: 2902104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates.
    Donzanti BA; Yamamoto BK
    Life Sci; 1988; 43(11):913-22. PubMed ID: 2901021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of neurochemicals in biological fluids by using an automated high-performance liquid chromatographic system with a coulometric array detector.
    Rizzo V; d'Eril GM; Achilli G; Cellerino GP
    J Chromatogr; 1991 Jan; 536(1-2):229-36. PubMed ID: 1675641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of amino acids: neurochemical application.
    Sandberg M; Hagberg H; Jacobson I; Karlsson B; Lehmann A; Hamberger A
    Life Sci; 1987 Aug; 41(7):829-32. PubMed ID: 2886876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-medical applications of high performance liquid chromatography (HPLC) with amperometric detection.
    Causon R; Davies D; Brown M
    Life Sci; 1987 Aug; 41(7):909-12. PubMed ID: 2886884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.
    Beal MF; Matson WR; Swartz KJ; Gamache PH; Bird ED
    J Neurochem; 1990 Oct; 55(4):1327-39. PubMed ID: 2144582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of multiple redox-active compounds by high-performance liquid chromatography with coulometric multi-electrode array system.
    Yao JK; Cheng P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):93-100. PubMed ID: 15358312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
    Walsh FX; Bird ED; Stevens TJ
    Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
    [No Abstract]   [Full Text] [Related]  

  • 12. High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics.
    Kristal BS; Shurubor YI; Kaddurah-Daouk R; Matson WR
    Methods Mol Biol; 2007; 358():159-74. PubMed ID: 17035686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative and quantitative high performance liquid chromatographic analysis of monoamine neurotransmitters and metabolites in cerebrospinal fluid and brain tissue using reductive electrochemical detection.
    Schmidt D; Roznoski M; Ebert MH
    Biomed Chromatogr; 1990 Sep; 4(5):215-20. PubMed ID: 1980626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amino acid metabolism in neurodegenerative diseases].
    Nakamura S
    Nihon Rinsho; 1992 Jul; 50(7):1637-42. PubMed ID: 1357203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain.
    Patassini S; Begley P; Xu J; Church SJ; Reid SJ; Kim EH; Curtis MA; Dragunow M; Waldvogel HJ; Snell RG; Unwin RD; Faull RL; Cooper GJ
    Biochim Biophys Acta; 2016 Sep; 1862(9):1650-62. PubMed ID: 27267344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies.
    Perry TL; Hansen S
    Neurology; 1990 Jan; 40(1):20-4. PubMed ID: 1967491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.
    Sathyasaikumar KV; Stachowski EK; Amori L; Guidetti P; Muchowski PJ; Schwarcz R
    J Neurochem; 2010 Jun; 113(6):1416-25. PubMed ID: 20236387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of neurotransmitter amino acids by high-performance liquid chromatography with fluorescence detection.
    Zecca L; Ferrario P
    J Chromatogr; 1985 Feb; 337(2):391-6. PubMed ID: 2859298
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.